Sensitization of Neuronal Cells to Oxidative Stress with Mutated Human α‐Synuclein

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Neurochemistry

• Publication date

  2000-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1471-4159.2000.0752546.x
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Physiology and Anatomy of Possible Oscillators in the Central Nervous System

  2008cited by this paper
• α‐Synuclein Up‐Regulation in Substantia Nigra Dopaminergic Neurons Following Administration of the Parkinsonian Toxin MPTP

  2000cited by this paper
• Dityrosine Cross-linking Promotes Formation of Stable α-Synuclein Polymers

  2000cited by this paper
• Chaperone‐like activity of synucleins

  2000cited by this paper
• Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells.

  2000cited by this paper
• Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation.

  2000cited by this paper
• Alpha-synuclein overexpression promotes aggregation of mutant huntingtin.

  2000cited by this paper
• Mutant and Wild Type Human α-Synucleins Assemble into Elongated Filaments with Distinct Morphologies in Vitro *

  1999cited by this paper
• Oxidative Stress in Neurological Disease

  1999cited by this paper
• α-Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins

  1999influential reference
• Both Familial Parkinson’s Disease Mutations Accelerate α-Synuclein Aggregation*

  1999cited by this paper
• Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro.

  1999cited by this paper
• α-Synuclein Binds to Tau and Stimulates the Protein Kinase A-catalyzed Tau Phosphorylation of Serine Residues 262 and 356*

  1999cited by this paper
• Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions

  1999cited by this paper
• Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro

  1999cited by this paper
• Widespread Alterations of α-Synuclein in Multiple System Atrophy

  1999cited by this paper
• Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes*

  1998cited by this paper
• Nigral and Cortical Lewy Bodies and Dystrophic Nigral Neurites in Parkinson's Disease and Cortical Lewy Body Disease Contain α-synuclein Immunoreactivity

  1998cited by this paper
• Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synuclein

  1998cited by this paper
• NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy

  1998cited by this paper
• α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies

  1998cited by this paper
• The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease.

  1998cited by this paper
• Low frequency of α‐synuclein mutations in familial Parkinson's disease

  1998cited by this paper
• Understanding cell death in parkinson's disease

  1998cited by this paper
• Binding of α-Synuclein to Brain Vesicles Is Abolished by Familial Parkinson’s Disease Mutation*

  1998cited by this paper
• Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins.

  1998cited by this paper
• Protein Nitration in Parkinson's Disease

  1998cited by this paper
• Oxidative mechanisms in nigral cell death in Parkinson's disease.

  1998cited by this paper
• Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease

  1998cited by this paper
• Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

  1998influential reference
• Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease

  1998cited by this paper
• Aggregates from mutant and wild‐type α‐synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β‐sheet and amyloid‐like filaments

  1998cited by this paper
• AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

  1998cited by this paper
• The G209A mutation in the alpha-synuclein gene is not detected in familial cases of Parkinson disease in non-Greek and/or Italian populations.

  1998cited by this paper
• Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies.

  1998cited by this paper
• Alpha synuclein in neurodegenerative disorders: Murderer or accomplice?

  1998cited by this paper
• Sequencing of the α-Synuclein Gene in a Large Series of Cases of Familial Parkinson's Disease Fails to Reveal any Further Mutations

  1998cited by this paper
• Menadione-induced tau dephosphorylation in cultured human neuroblastoma cells.

  1997influential reference
• Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

  1997influential reference
• Bcl-2 gene family in the nervous system.

  1997cited by this paper
• α-Synuclein in Lewy bodies

  1997cited by this paper
• Modulated induction of tau proteins in cultured human neuroblastoma cells.

  1996cited by this paper
• Immobilization of the C-terminal Extension of Bovine αA-Crystallin Reduces Chaperone-like Activity*

  1996cited by this paper
• Conformational Properties of Substrate Proteins Bound to a Molecular Chaperone -Crystallin (*)

  1996cited by this paper
• Characterization of the Precursor Protein of the Non-Aβ Component of Senile Plaques (NACP) in the Human Central Nervous System

  1996cited by this paper
• The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

  1995cited by this paper
• Identification of two distinct synucleins from human brain

  1994cited by this paper
• Characterization of 2',7'-dichlorofluorescin fluorescence in dissociated mammalian brain neurons: estimation on intracellular content of hydrogen peroxide.

  1994cited by this paper
• Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.

  1993cited by this paper
• Expression in cultured human neuroblastoma cells of epitopes associated with affected neurons in Alzheimer's disease.

  1990cited by this paper
• Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages.

  1989cited by this paper
• Altered thiol and calcium homeostasis in oxidative hepatocellular injury

  1985cited by this paper
• Menadione-induced cytotoxicity is associated with protein thiol oxidation and alteration in intracellular Ca2+ homeostasis.

  1984cited by this paper
• The metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes. A study of the implications of oxidative stress in intact cells.

  1982cited by this paper

• The Role of Oxidative Stress in Parkinson’s Disease

  2020cites this paper
• The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease

  2019cites this paper
• Alpha-Synuclein Disease Mutations Are Structurally Defective and Locally Affect Membrane Binding.

  2017cites this paper
• Individual Amino Acid Supplementation Can Improve Energy Metabolism and Decrease ROS Production in Neuronal Cells Overexpressing Alpha-Synuclein

  2017cites this paper
• MPTP-induced vulnerability of dopamine neurons in A53T α-synuclein overexpressed mice with the potential involvement of DJ-1 downregulation

  2017cites this paper
• Alpha-synuclein-induced oxidative stress correlates with altered superoxide dismutase and glutathione synthesis in human neuroblastoma SH-SY5Y cells

  2016cites this paper
• Mechanisms of Alpha-Synuclein Action on Neurotransmission: Cell-Autonomous and Non-Cell Autonomous Role

  2015cites this paper
• Overexpression of alpha-synuclein at non-toxic levels increases dopaminergic cell death induced by copper exposure via modulation of protein degradation pathways.

  2015cites this paper
• Combined exposure to agriculture pesticides, paraquat and maneb, induces alterations in the N/OFQ—NOPr and PDYN/KOPr systems in rats: Relevance to sporadic Parkinson's disease

  2015cites this paper
• The role of alpha-synuclein phosphorylation in synucleinopathies

  2014cites this paper
• α‐synuclein‐induced mitochondrial dysfunction in isolated preparation and intact cells: Implications in the pathogenesis of Parkinson's disease

  2014cites this paper
• Antioxidant gene therapy against neuronal cell death.

  2014cites this paper
• E3 Ubiquitin Ligases in Protein Quality Control Mechanism

  2012cites this paper
• Towards New Therapies for Parkinson's Disease

  2011cites this paper
• Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism.

  2011cites this paper
• Alpha-Synuclein and the Immune Response in Parkinson’s Disease

  2011cites this paper
• pragmatic approach to biochemical systems theory applied to an-synuclein-based model of Parkinson ’ s disease

  2009cites this paper
• Protection against paraquat and A53T alpha-synuclein toxicity by cabergoline is partially mediated by dopamine receptors.

  2009cites this paper
• Molecular mechanisms of alpha-synuclein neurodegeneration.

  2009cites this paper
• Immunological features of α-synuclein in Parkinson's disease

  2008cites this paper
• Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and α-synuclein-deleted mice

  2008cites this paper
• Increased Dopaminergic Neuron Sensitivity to 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) in Transgenic Mice Expressing Mutant A53T α-Synuclein

  2008cites this paper
• Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis

  2008cites this paper
• Aggregates Assembled From Overexpression of Wild-Type &agr;-Synuclein are not Toxic to Human Neuronal Cells

  2008cites this paper
• Neuropathology, biochemistry, and biophysics of α‐synuclein aggregation

  2007cites this paper
• α-Synuclein Aggregation and Parkinson’s Disease

  2007cites this paper
• Melatonin protects SK‐N‐SH neuroblastoma cells from amphetamine‐induced neurotoxicity

  2007cites this paper
• Parkinson's Disease: Genetics and Pathogenesis

  2007cites this paper
• Parkinson's disease: genetics and beyond.

  2007cites this paper
• Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death.

  2007cites this paper
• Genetics in Parkinson's disease

  2006cites this paper
• Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system.

  2006cites this paper
• Mice lacking alpha-synuclein are resistant to mitochondrial toxins.

  2006cites this paper
• Upregulation of α-synuclein in neurons and glia in inflammatory demyelinating disease

  2006cites this paper
• Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures.

  2005cites this paper
• Wild-type α-synuclein interacts with pro-apoptotic proteins PKCδ and BAD to protect dopaminergic neuronal cells against MPP+-induced apoptotic cell death

  2005cites this paper
• Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity.

  2005cites this paper
• Viral Vector Mediated Overexpression of Human α-Synuclein in the Nigrostriatal Dopaminergic Neurons: A New Model for Parkinson's Disease

  2005cites this paper
• Antiapoptotic property of human α‐synuclein in neuronal cell lines is associated with the inhibition of caspase‐3 but not caspase‐9 activity

  2005cites this paper
• CHAPTER B4 – Rotenone Rat and Other Neurotoxin Models of Parkinson Disease

  2005cites this paper
• Molecular pathophysiology of Parkinson's disease.

  2005cites this paper
• Neurobiology of α-synuclein

  2004cites this paper
• Tyrosine-to-Cysteine Modification of Human α-Synuclein Enhances Protein Aggregation and Cellular Toxicity*

  2004cites this paper
• G209A mutant alpha synuclein expression specifically enhances dopamine induced oxidative damage.

  2004cites this paper
• α‐Synuclein induces apoptosis by altered expression in human peripheral lymphocytes in Parkinson’s disease

  2004cites this paper
• Alpha-synuclein: normal function and role in neurodegenerative diseases.

  2004cites this paper
• α-Synuclein, Parkinson's disease, and Alzheimer's disease

  2004cites this paper
• HSP27 but not HSP70 has a potent protective effect against α‐synuclein‐induced cell death in mammalian neuronal cells

  2004cites this paper
• -Synuclein: Normal Function and Role in Neurodegenerative Diseases

  2004cites this paper
• Tissue transglutaminase is not involved in the aggregate formation of stably expressed α-synuclein in sh-sy5y human neuroblastoma cells

  2004cites this paper
• Autosomal recessive, early-onset Parkinson’s disease

  2003cites this paper
• Co‐ordinate transcriptional regulation of dopamine synthesis genes by α‐synuclein in human neuroblastoma cell lines

  2003cites this paper
• Models of Parkinson's disease

  2003cites this paper
• Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation.

  2003cites this paper
• Mechanism of Toxicity in Rotenone Models of Parkinson's Disease

  2003cites this paper
• Polymorphisms of the α-synuclein promoter: expression analyses and association studies in Parkinson's disease

  2003cites this paper
• Modulation of cell death by α-synuclein is stimulus-dependent in mammalian cells

  2003cites this paper
• Part II: α-synuclein and its molecular pathophysiological role in neurodegenerative disease

  2003cites this paper
• α-Synuclein Aggregation: A Link Between Mitochondrial Defects and Parkinson's Disease?

  2003cites this paper
• Mitochondrial Mutations in Parkinson's Disease and Dystonias

  2003cites this paper
• Models of repair mechanisms for future treatment modalities of Parkinson's disease.

  2002cites this paper
• MPP+ increases α-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells

  2002cites this paper
• Mutant and wild-type α-synuclein interact with mitochondrial cytochrome C oxidase

  2002cites this paper
• Molecular Biology of α-Synuclein

  2002cites this paper
• Parkin Protects against the Toxicity Associated with Mutant α-Synuclein: Proteasome Dysfunction Selectively Affects Catecholaminergic Neurons

  2002cites this paper
• Mechanistic Approaches to Parkinson's Disease Pathogenesis

  2002cites this paper
• Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP.

  2002cites this paper
• An In Vitro Model of Parkinson's Disease: Linking Mitochondrial Impairment to Altered α-Synuclein Metabolism and Oxidative Damage

  2002cites this paper
• Amyloid Precursor Protein, Presenilins, and α-Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease

  2002cites this paper
• Neuroprotection and dopamine agonists

  2002cites this paper
• α-Synuclein Protects against Oxidative Stress via Inactivation of the c-Jun N-terminal Kinase Stress-signaling Pathway in Neuronal Cells*

  2002cites this paper
• Protein misfolding in Alzheimer's and Parkinson's disease: genetics and molecular mechanisms.

  2002cites this paper
• Mapping the Progress of Alzheimer’s and Parkinson’s Disease

  2002cites this paper
• Mitochondrial involvement in Parkinson's disease.

  2002cites this paper
• α-Synuclein and the Lewy body disorders

  2001cites this paper
• Alpha Synuclein Aggregation in a Neurotoxic Model of Parkinson's Disease

  2001cites this paper
• Prominent Perikaryal Expression of α- and β-Synuclein in Neurons of Dorsal Root Ganglion and in Medullary Neurons

  2001cites this paper
• Lewy body pathology in Alzheimer’s disease

  2001cites this paper
• Antisense strategies for the treatment of neurological disease

  2001cites this paper
• Biochemical analysis of cybrids expressing mitochondrial DNA from Contursi kindred Parkinson's subjects.

  2001cites this paper
• Alpha-synuclein and the Lewy body disorders.

  2001cites this paper
• Induction of α-Synuclein Aggregation by Intracellular Nitrative Insult

  2001cites this paper
• Estudios de asociación genética y detección de mutaciones en pacientes con enfermedad de Parkinson. Comparación genético-clínica entre los casos esporádicos y familiares.

  2001cites this paper
• Expression of A53T Mutant But Not Wild-Type α-Synuclein in PC12 Cells Induces Alterations of the Ubiquitin-Dependent Degradation System, Loss of Dopamine Release, and Autophagic Cell Death

  2001cites this paper
• Induction of Neuronal Cell Death by Rab5A-dependent Endocytosis of α-Synuclein*

  2001cites this paper
• 6-Hydroxydopamine Increases Ubiquitin-Conjugates and Protein Degradation: Implications for the Pathogenesis of Parkinson's Disease

  2001cites this paper